Last reviewed · How we verify
NCT03509428: WesFit
The Wessex Fit-4-Cancer Surgery Trial
NA trial testing SRETP in Cancer in 1,560 participants. Status unknown.
1 March 2021
Quick facts
| Lead sponsor | University Hospital Southampton NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 1,560 |
| Start date | 26 March 2018 |
| Primary completion | 1 March 2021 |
| Estimated completion | 1 March 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- SRETP
- Psychological support
Conditions studied
- Cancer — all drugs for Cancer →
Sponsor
University Hospital Southampton NHS Foundation Trust
Who can join
18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Trial Phase: Phase III: A multi-centre efficacy pragmatic factorial design randomised controlled trial with patient informed development and process evaluation Indication: Patients undergoing major electively resectable intra - cavity cancer surgery with or without neoadjuvant cancer treatments (including chemotherapy (NAC), chemoradiotherapy (CRT), or immunotherapy). Objective: To investigate the efficacy of a community based Structured Responsive Exercise-training Programme (SRETP) ± psychological support on surgical outcome by reducing postoperative length of stay (LOS) and complications. Secondary Objective: To investigate the efficacy of a community based Structured Responsive Exercise-training Programme (SRETP) ± psychological support to improve disease-free overall survival. Cardiopulmonary Exercise test (CPET) variables, physical activity, morbidity, radiological markers of sarcopenia, toxicity, tumour down-staging, tumour regression, disability adjusted survival (WHODAS) overall survival and quality of life (QoL).
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Efficacy of Prehabilitation Including Exercise on Postoperative Outcomes Following Abdominal Cancer Surgery: A Systematic Review and Meta-Analysis.
Waterland JL, McCourt O, Edbrooke L, Granger CL, et al · · 2021 · cited 126× · PMID 33816546 · DOI 10.3389/fsurg.2021.628848 -
'Fit for surgery': the relationship between cardiorespiratory fitness and postoperative outcomes.
Rose GA, Davies RG, Appadurai IR, Williams IM, et al · · 2022 · cited 35× · PMID 35579479 · DOI 10.1113/ep090156 -
Exercise interventions for people undergoing multimodal cancer treatment that includes surgery.
Loughney LA, West MA, Kemp GJ, Grocott MP, et al · · 2018 · cited 29× · PMID 30536366 · DOI 10.1002/14651858.cd012280.pub2 -
The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients: a randomised controlled trial (The EMPOWER Trial).
Loughney L, West MA, Moyses H, Bates A, et al · · 2021 · cited 28× · PMID 34154675 · DOI 10.1186/s13741-021-00190-8 -
The time course of physiological adaptations to high-intensity interval training in older adults.
Herrod PJJ, Blackwell JEM, Boereboom CL, Atherton PJ, et al · · 2020 · cited 17× · PMID 33392430 · DOI 10.1002/agm2.12127 -
The Wessex Fit-4-Cancer Surgery Trial (WesFit): a protocol for a factorial-design, pragmatic randomised-controlled trial investigating the effects of a multi-modal prehabilitation programme in patients undergoing elective major intra-cavity cancer surgery.
West M, Bates A, Grimmett C, Allen C, et al · · 2021 · cited 13× · PMID 36247802 · DOI 10.12688/f1000research.55324.2 -
Multivisceral Resection of Advanced Pelvic Tumors: From Planning to Implementation.
Mirnezami R, Mirnezami A. · · 2020 · cited 6× · PMID 32968362 · DOI 10.1055/s-0040-1713744 -
The Wessex Fit-4-Cancer Surgery Trial (WesFit): a protocol for a factorial-design, pragmatic randomised-controlled trial investigating the effects of a multi-modal prehabilitation programme in patients undergoing elective major intra–cavity cancer surgery
West M, Bates A, Grimmett C, Allen C, et al · · 2022 · DOI 10.12688/f1000research.55324.2
Verify or expand the search:
- PubMed search for NCT03509428
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other University Hospital Southampton NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07354971 — IMMUNO-FIT Observational Study · not yet recruiting
- NCT07278622 — Virtual Group Prehabilitation Education (Surgery School) Feasibility Trial · NA · recruiting
- NCT07357558 — A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary · recruiting
- NCT06851715 — Improving Quality of Life for Teenagers With Asthma · NA · recruiting
- NCT07489677 — The Feasibility and Acceptability of a Collaborative Deprescribing Intervention to Reduce Anticholinergic Burden Among H · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03509428 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Southampton NHS Foundation Trust
- Last refreshed: 9 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03509428.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing